Fifty-third ACBTSA Meeting: August 17-18, 2021

August 17, 2021 - August 18, 2021

The Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA) convened on August 17-18, 2021 to conduct the fifty-third meeting.

Agenda

August 17, 2021

TIMEAGENDA ITEMSPEAKER 
Committee Business 
9:30Doors Open (committee members to join 15-30 minutes prior)
All timings listed are in ET		 
10:00WelcomeJackie Fredrick, MT (ASCP) SBB, MBA, Hon DB/DPH, Chair ACBTSA 
10:05Roll callJames Berger, MS, MT (ASCP) SBB, Designated Federal Officer, ACBTSA 
10:10Call to OrderJames Berger, MS, MT (ASCP) SBB 
10:15Purpose of the Meeting and Questions for the CommitteeJackie Fredrick, MT (ASCP) SBB, MBA, Hon DB/DPH 
10:30Welcome and CommentsRachel L. Levine, MD, Assistant Secretary of Health 
10:45Review Recommendations in the HHS Adequacy of the National Blood Supply: Report to Congress, 2020 and ACBTSA Recommendations to the ASH, September 2020Jackie Fredrick, MT (ASCP) SBB, MBA, Hon DB/DPH 
11:00Public CommentsJames Berger, MS, MT (ASCP) SBB 
Supply Chain to Produce Blood Products, Recommendation 3 
11:30Common Definition of Supply ChainSally Caglioti, MS, MT (ASCP), President & CEO, Creative Testing Solutions 
11:45

Lessons Learned from the COVID-19 Pandemic

  • Inside a Pandemic: An Academic Medical Center’s Response
  • BCA’s COVID-19 Experience
  • The Canadian Experience

Jackie Fredrick, MT (ASCP) SBB, MBA, Hon DB/DPH to serve as Moderator

  • Eric L. Conley, Executive Vice President, Froedtert Health, President, Froedtert Hospital
  • Bill Block, CEO and President, Blood Centers of America, Inc.
  • Dr. Graham Sher, MD PhD, Chief Executive Officer, Canadian Blood Services
 
12:45Q&A/DiscussionJackie Fredrick, MT (ASCP) SBB, MBA, Hon DB/DPH to serve as Moderator 
1:15Lunch
1:45Identification and Prioritization of Key Risk Drivers for the Dutch Blood Supply

David Perez, Board Member, Retired President & CEO of Terumo BCT to serve as Moderator

  • Mart P. Janssen, PhD, Principal Investigator Transfusion Technology Assessment, Sanquin Research Amsterdam, The Netherlands
  • Syeldy Langi Sasongko, MSc, PhD student, Transfusion Technology Assessment, Sanquin Research Amsterdam, The Netherlands
 
2:30Q&A/DiscussionDavid Perez, Board Member, Retired President & CEO of Terumo BCT to serve as Moderator 
2:45Break
3:00Risk Management: Impact of the COVID-19 Pandemic

Sally Caglioti, MS, MT (ASCP) and David Perez to serve as Moderators

  • Sally Caglioti, MT (ASCP) SBB
  • Bill Block, CEO and President, Blood Centers of America, Inc.
  • David R. Green, President/CEO, Vitalant
  • Eric Santiago-Justiniano, MBA, Vice President Operations, Fresenius Kabi Puerto Rico; Chief Financial Officer, Fenwal International, Inc.; Vice President Operations, Fresenius Kabi Puerto Rico
  • Michael P. Angelastro, Director, Division of Pharmaceutical Countermeasures Infrastructure, Biomedical Advanced Research & Development Authority, Assistant Secretary for Preparedness & Response, U.S. Department of Health & Human Services
  • Claudia S. Cohn, MD, PhD, Professor of Laboratory Medicine and Pathology, University of Minnesota, Chief Medical Officer, AABB
  • Steven M. Frank, MD, Professor, Department of Anesthesiology/Critical Care Medicine, Director, Johns Hopkins Health System Blood Management Program, Director, Center for Bloodless Medicine and Surgery Johns Hopkins Medical Institutions
 
5:00Committee Discussion and Recommendation FormulationSally Caglioti, MS, MT (ASCP) and David Perez 
6:00Committee Recommendations Summary and VoteJackie Fredrick, MT (ASCP) SBB, MBA, Hon DB/DPH 
6:15Wrap-up and AdjournmentJackie Fredrick, MT (ASCP) SBB, MBA, Hon DB/DPH and James Berger, MS, MT (ASCP) SBB 

August 18, 2021

TIMEAGENDA ITEMSPEAKER 
Committee Business 
9:30Doors Open (committee members to join 15-30 minutes prior)
All timings listed are in ET		 
10:00Roll CallJames Berger, MS, MT (ASCP) SBB 
10:05Call to OrderJames Berger, MS, MT (ASCP) SBB 
Data Infrastructure Solutions, Recommendation 5 
10:10Introduction and Outline the GoalClaudia Cohn, MD, PhD 
10:40Revision of the EU Blood Legislation – Lessons from COVIDDeirdre Fehily, PhD, Policy Officer, Substances of Human Origin, DG Santé, European Commission 
11:00Blood Donors as a Sentinel PopulationChristian Erikstrup, MD, PhD, Chair Professor, Consultant, Department of Clinical Immunology, Aarhus University Hospital, Department of Clinical Medicine, Aarhus University 
11:25Q&A/DiscussionMatthew J. Kuehnert, MD to serve as Moderator 
11:55Lunch
12:25AABB Interorganizational Task Force – US Perspective on Blood Supply and Inventory DataLeo DeBandi, Vice President, Analytics, Production and Inventory Planning, American Red Cross 
12:55National Data Warehouse for BloodMartin Grable, Executive Vice President, Chief Financial and Administrative Officer,
OneBlood John Mass, Vice President Biomedical Services Business Systems, American Red Cross		 
1:25Q&A/Discussion (for US Network and Blood Center Networks)Matthew J. Kuehnert, MD to serve as Moderator 
1:55Recipient Hemovigilance – How to Enable and/or Encourage Hospitals to Provide DataChester Andrzejewski, PhD, MD, FCAP, Director of System Blood Banking and Transfusion/Apheresis Medicine Services, Baystate Health, Assistant Professor, Department of Pathology, University of Massachusetts Medical School-Baystate Melissa Cumming, MS, CIC, Senior Epidemiologist, Healthcare-Associated Infections and Antibiotic Resistance Program Lead, Bureau of Infectious Disease and Laboratory Sciences,
Massachusetts Department of Public Health		 
2:40Q&A/DiscussionMatthew J. Kuehnert, MD to serve as Moderator 
2:55Break
3:10Focus on Comparative Blood UtilizationDavid Levine, MD, FACEP, Group Senior Vice President, Advanced Analytics and Data Science, Vizient, Inc. Saloni Kapur Jain, PharmD, MPA, Vice President, Advanced Analytics and Informatics, Vizient, Inc. 
3:55Q&A/DiscussionMatthew J. Kuehnert, MD, to serve as Moderator 
4:10Donor Data for Public HealthBrian Custer, PhD, MPH, Director, Epidemiology and Health Policy Science
Vice President, Research and Scientific Programs, Vitalant Research Institute,
Adjunct Professor, Laboratory Medicine, UCSF		 
4:55Q&A/DiscussionMatthew J. Kuehnert, MD, to serve as Moderator 
5:10Committee Discussion and Recommendation FormulationMatthew J. Kuehnert, MD, and Claudia Cohn, MD, PhD 
Discussion and Process for Formulation of Recommendations 
6:15Committee Recommendation Summary and VoteJackie Fredrick, MT (ASCP) SBB, MBA, Hon DB/DPH 
6:30AdjournmentJames Berger, MS, MT (ASCP) SBB 

The fifty-third ACBTSA meeting was held on August 17-18, 2021.

During this meeting, the committee discussed recommendations related to supply chain resiliency and data infrastructure to support the blood and plasma industries. The Committee elected to deliberate potential recommendations to submit to the Assistant Secretary for Health among work groups and reconvene to vote on such recommendations during fifty-fourth meeting, scheduled for September 23, 2021.

Meeting Summary

Federal Register Notice

View the Meeting Recording

Content last reviewed